Brief: Dr Reddy's Announces First-To-Market Launch Of Bosutinib Tablets 400Mg In The United States
13/06/2026 09:12
BRIEF-Dr Reddy's Announces First-To-Market Launch Of Bosutinib Tablets 400Mg In The United States June 13 (Reuters) - Dr Reddy's Laboratories Ltd REDY.NS:
DR REDDY'S - ANNOUNCES THE FIRST-TO-MARKET LAUNCH OF BOSUTINIB TABLETS 400MG IN THE UNITED STATES
Source text: ID:nPLXQ94HLR
Further company coverage: REDY.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Dr Reddys Laboratories
See all newsFocus: US progesterone supplies tighten as menopause treatment demand grows
Factbox: Global drugmakers invest billions to boost US presence
Brief: Dr Reddy's Announces First-To-Market Launch Of Bosutinib Tablets 400Mg In The United States
Advisory: Inadvertently published alert on NYSE tagged to multiple companies withdrawn
Hims offers Apotex's generic semaglutide in Canada after Novo patent expiry (updated)